Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases
Clinical trial NCT04461418 · TERMINATED
Trial details
- NCT number
- NCT04461418
- Sponsor
- AHS Cancer Control Alberta
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-30
- Primary completion
- 2023-09-23
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.